title: Postcoronary thrombolysis management.
authors.forename: D
authors.initials: D
authors.lastname: Massel
authors.forename: J A
authors.initials: JA
authors.lastname: Cairns
authors.forename: P W
authors.initials: PW
authors.lastname: Armstrong
authors.forename: M
authors.initials: M
authors.lastname: Knudtson
authors.forename: M
authors.initials: M
authors.lastname: Lemieux
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D017202:Myocardial Ischemia / Q000517:prevention & control; D011379:Prognosis; D012008:Recurrence; D015912:Thrombolytic Therapy
chemical_list: D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D001241:Aspirin